Paradigm Biocapital Advisors LP Poseida Therapeutics, Inc. Transaction History

Paradigm Biocapital Advisors LP

  • $2.77 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$3.08 - $8.73 $4.2 Million - $11.9 Million
-1,362,406 Reduced 55.96%
1,072,410 $3.3 Million
Q4 2022

Feb 14, 2023
BUY
$3.33 - $6.38 $1.21 Million - $2.33 Million
364,708 Added 17.62%
2,434,816 $12.9 Million
Q3 2022

Nov 14, 2022
BUY
$2.43 - $4.51 $5.03 Million - $9.34 Million
2,070,108 New
2,070,108 $7.31 Million

Others Institutions Holding PSTX

# of Institutions
97
Shares Held
38.5M
Call Options Held
377K
Put Options Held
22.2K
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $237M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email